Mutational paths towards increased fluoroquinolone resistance in Legionella pneumophila
- PMID:19474069
- DOI: 10.1093/jac/dkp173
Mutational paths towards increased fluoroquinolone resistance in Legionella pneumophila
Abstract
Objectives: Fluoroquinolone resistance has been poorly studied in Legionella pneumophila, an intracellular pathogen responsible for legionellosis. Our goal was to further characterize molecular mechanisms involved in fluoroquinolone resistance in this species.
Methods: Eight independent lineages were founded from a common fluoroquinolone-susceptible L. pneumophila ancestor and propagated by serial passages in moxifloxacin-containing culture medium. We identified the substituted mutations that affected the DNA topoisomerase II-encoding genes, determined the order of substitution of the mutations leading to the stepwise MIC increases of moxifloxacin over evolutionary time and demonstrated their direct involvement in the resistance process.
Results: Adaptation occurred through parallel stepwise increases in the moxifloxacin MICs up to 512-fold the MIC for the parental strain. Mutations affected the topoisomerase II-encoding genes gyrA, parC and gyrB, reflecting a high degree of genetic parallelism across the independent lineages. During evolution, the T83I change in GyrA occurred first, followed by G78D or S80R in ParC and D87N in GyrA, or S464Y or D426N in GyrB. By constructing isogenic strains, we showed that the progressive increase in resistance was linked to a precise order of mutation substitution, but also to the co-existence of several subpopulations of bacteria bearing different mutations.
Conclusions: Specific mutational trajectories were identified, strongly suggesting that intermolecular epistatic interactions between DNA topoisomerases underlie the mechanism of fluoroquinolone resistance in L. pneumophila. Our results suggest that L. pneumophila has strong potential to become resistant to fluoroquinolone compounds and warrant further investigation of resistance in clinical and environmental strains of this pathogen.
Similar articles
- Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.Malhotra-Kumar S, Van Heirstraeten L, Lammens C, Chapelle S, Goossens H.Malhotra-Kumar S, et al.J Antimicrob Chemother. 2009 May;63(5):886-94. doi: 10.1093/jac/dkp057. Epub 2009 Mar 11.J Antimicrob Chemother. 2009.PMID:19279051
- Comparison of full gyrA, gyrB, parC and parE gene sequences between all Ureaplasma parvum and Ureaplasma urealyticum serovars to separate true fluoroquinolone antibiotic resistance mutations from non-resistance polymorphism.Beeton ML, Chalker VJ, Kotecha S, Spiller OB.Beeton ML, et al.J Antimicrob Chemother. 2009 Sep;64(3):529-38. doi: 10.1093/jac/dkp218. Epub 2009 Jun 30.J Antimicrob Chemother. 2009.PMID:19567408
- The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.Turner AK, Nair S, Wain J.Turner AK, et al.J Antimicrob Chemother. 2006 Oct;58(4):733-40. doi: 10.1093/jac/dkl333. Epub 2006 Aug 8.J Antimicrob Chemother. 2006.PMID:16895934
- Molecular mechanisms of fluoroquinolone resistance.Chen FJ, Lo HJ.Chen FJ, et al.J Microbiol Immunol Infect. 2003 Mar;36(1):1-9.J Microbiol Immunol Infect. 2003.PMID:12741725Review.
- [Mutation window for the "pneumococcus-fluoroquinolone" couple. Contribution of experimental models].Chavanet P, Croisier D.Chavanet P, et al.Med Mal Infect. 2006 Nov-Dec;36(11-12):614-24. doi: 10.1016/j.medmal.2006.07.013. Epub 2006 Nov 13.Med Mal Infect. 2006.PMID:17095175Review.French.
Cited by
- A Proactive Environmental Approach for Preventing Legionellosis in Infants: Water Sampling and Antibiotic Resistance Monitoring, a 3-Years Survey Program.Alexandropoulou I, Parasidis T, Konstantinidis T, Panopoulou M, Constantinidis TC.Alexandropoulou I, et al.Healthcare (Basel). 2019 Mar 8;7(1):39. doi: 10.3390/healthcare7010039.Healthcare (Basel). 2019.PMID:30857147Free PMC article.
- Link Between Antibiotic Persistence and Antibiotic Resistance in Bacterial Pathogens.Eisenreich W, Rudel T, Heesemann J, Goebel W.Eisenreich W, et al.Front Cell Infect Microbiol. 2022 Jul 19;12:900848. doi: 10.3389/fcimb.2022.900848. eCollection 2022.Front Cell Infect Microbiol. 2022.PMID:35928205Free PMC article.Review.
- Overview of the Clinical and Molecular Features of Legionella Pneumophila: Focus on Novel Surveillance and Diagnostic Strategies.Gattuso G, Rizzo R, Lavoro A, Spoto V, Porciello G, Montagnese C, Cinà D, Cosentino A, Lombardo C, Mezzatesta ML, Salmeri M.Gattuso G, et al.Antibiotics (Basel). 2022 Mar 9;11(3):370. doi: 10.3390/antibiotics11030370.Antibiotics (Basel). 2022.PMID:35326833Free PMC article.Review.
- Experimental evolution of pathogenesis: "patient" research.Ensminger AW.Ensminger AW.PLoS Pathog. 2013;9(5):e1003340. doi: 10.1371/journal.ppat.1003340. Epub 2013 May 30.PLoS Pathog. 2013.PMID:23737744Free PMC article.Review.No abstract available.
- Detection ofLegionella Anisa in Water from Hospital Dental Chair Units and Molecular Characterization by Whole-Genome Sequencing.Fleres G, Couto N, Lokate M, van der Sluis LWM, Ginevra C, Jarraud S, Deurenberg RH, Rossen JW, García-Cobos S, Friedrich AW.Fleres G, et al.Microorganisms. 2018 Jul 18;6(3):71. doi: 10.3390/microorganisms6030071.Microorganisms. 2018.PMID:30021964Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical